Success Story: NIW Approved Without RFE for Biomedical Science Research From China
Client’s Testimonial:
"Wow. Thanks for all the help.”
On February 5th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Research Fellow
State of Residence at the Time of Filing: Tennessee
Approval Notice Date: February 5th, 2026
Processing Time: 22 months, 8 days (Premium Processing Upgrade Requested)
Case Summary:
Sepsis and immune dysfunction diseases often escalate because clinicians still lack precise tools to predict who will deteriorate and which immune pathways can be safely targeted. The client’s work sits at that bottleneck, investigating how inflammasome activation and pyroptosis contribute to sepsis-related disease processes, and how genetic causes of inborn errors of immunity can be identified and characterized to enable new immunotherapies, including gene therapy and antibody therapies.
The client holds a Ph.D. in chemistry and currently conducts biomedical research at a U.S.-based academic medical center, where the client plans to continue collaborating with international networks to recruit families with suspected inborn errors of immunity and to apply integrative approaches such as next-generation sequencing and computational biology to discover and characterize these conditions. The long-term goal is to translate mechanistic and genetic insight into practical immunomodulatory treatments with broader disease applications.
Throughout the NIW petition, North America Immigration Law Group (Chen Immigration Law Associates) focused on presenting the endeavor in plain terms, then backing it with objective indicators that a non-specialist adjudicator can quickly verify. Instead of treating metrics as self-evident, we tied them to how the biomedical research community actually signals value: selective publication, independent reliance, and credible forward momentum.
To show the client is well-positioned to advance the endeavor, we organized the record around measurable, field-facing markers:
- Scholarly output: 6 peer-reviewed journal articles (including 1 first-authored) and 1 conference abstract
- Independent reliance: 134 citations to the client’s published work, including evidence that multiple papers achieved strong citation performance relative to field and publication year
- Funding validation: support linked to major U.S. biomedical funding institutions
Expert Recommendation Letters To corroborate the objective record, the petition included four letters of recommendation from established experts, including independent authorities. Strategically, these letters were used to translate complex biomedical mechanisms into clear value statements: why the client’s work on inflammasomes, pyroptosis, and immune genetic errors provides actionable insight for therapy development, and why the client’s trajectory supports continued contributions in the United States.
“His work is directly advancing research into systemic bacterial infections, fostering the development of enhanced clinical treatments, and improving patient health and satisfaction.”
Approval USCIS approved the I-140 National Interest Waiver petition, reflecting a record that tied a health-significant biomedical endeavor to concrete evidence of capability and influence. We are honored to have guided the client through the NIW process and to have presented the client’s work as a sustained, independently validated research direction with clear public-health relevance and continued forward potential.